OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 129 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $10,000 | -69.7% | 17,851 | 0.0% | 0.00% | – |
| Q4 2015 | $33,000 | -13.2% | 17,851 | 0.0% | 0.00% | – |
| Q3 2015 | $38,000 | -54.8% | 17,851 | 0.0% | 0.00% | – |
| Q2 2015 | $84,000 | -39.1% | 17,851 | 0.0% | 0.00% | – |
| Q1 2015 | $138,000 | +29.0% | 17,851 | 0.0% | 0.00% | – |
| Q4 2014 | $107,000 | +37.2% | 17,851 | 0.0% | 0.00% | – |
| Q3 2014 | $78,000 | – | 17,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $7,725,000 | 6.48% |
| Ghost Tree Capital, LLC | 250,000 | $1,545,000 | 1.09% |
| Rock Springs Capital Management LP | 905,000 | $5,593,000 | 1.00% |
| Palo Alto Investors LP | 1,931,324 | $11,936,000 | 0.89% |
| PFM Health Sciences, LP | 4,604,958 | $28,459,000 | 0.57% |
| NEA Management Company, LLC | 1,935,300 | $11,960,000 | 0.56% |
| Rhenman & Partners Asset Management AB | 300,199 | $1,855,000 | 0.55% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,752,792 | $10,832,000 | 0.50% |
| CQS Cayman LP | 660,040 | $4,079,000 | 0.25% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,684,300 | $16,589,000 | 0.24% |